Madrigal Pharmaceuticals, Inc. (FRA:YDO1)

Madrigal Pharmaceuticals Statistics

Total Valuation

FRA:YDO1 has a market cap or net worth of EUR 8.47 billion. The enterprise value is 7.93 billion.

Market Cap	8.47B
Enterprise Value	7.93B

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	22.94M
Shares Outstanding	n/a
Shares Change (YoY)	+5.46%
Shares Change (QoQ)	+1.54%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.38
PB Ratio	16.50
P/TBV Ratio	16.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-32.30
EV / Sales	9.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-49.00

Financial Position

The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.58.

Current Ratio	4.01
Quick Ratio	3.60
Debt / Equity	0.58
Debt / EBITDA	n/a
Debt / FCF	-1.83
Interest Coverage	-13.45

Financial Efficiency

Return on equity (ROE) is -42.49% and return on invested capital (ROIC) is -20.56%.

Return on Equity (ROE)	-42.49%
Return on Assets (ROA)	-16.30%
Return on Invested Capital (ROIC)	-20.56%
Return on Capital Employed (ROCE)	-31.61%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	892,100
Profits Per Employee	-268,340
Employee Count	528
Asset Turnover	0.83
Inventory Turnover	1.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+11.59%
50-Day Moving Average	439.37
200-Day Moving Average	360.45
Relative Strength Index (RSI)	33.47
Average Volume (20 Days)	17

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	11.65

Income Statement

In the last 12 months, FRA:YDO1 had revenue of EUR 816.27 million and -245.53 million in losses. Loss per share was -10.94.

Revenue	816.27M
Gross Profit	768.45M
Operating Income	-255.59M
Pretax Income	-245.53M
Net Income	-245.53M
EBITDA	-254.31M
EBIT	-255.59M
Loss Per Share	-10.94

Balance Sheet

The company has 837.70 million in cash and 296.08 million in debt, with a net cash position of 541.62 million.

Cash & Cash Equivalents	837.70M
Total Debt	296.08M
Net Cash	541.62M
Net Cash Per Share	n/a
Equity (Book Value)	513.31M
Book Value Per Share	22.47
Working Capital	796.75M

Cash Flow

In the last 12 months, operating cash flow was -161.44 million and capital expenditures -397,744, giving a free cash flow of -161.84 million.

Operating Cash Flow	-161.44M
Capital Expenditures	-397,744
Free Cash Flow	-161.84M
FCF Per Share	n/a

Margins

Gross margin is 94.14%, with operating and profit margins of -31.31% and -30.08%.

Gross Margin	94.14%
Operating Margin	-31.31%
Pretax Margin	-30.08%
Profit Margin	-30.08%
EBITDA Margin	-31.16%
EBIT Margin	-31.31%
FCF Margin	n/a

Dividends & Yields

FRA:YDO1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.46%
Shareholder Yield	-5.46%
Earnings Yield	-2.90%
FCF Yield	-1.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 25, 2016. It was a reverse split with a ratio of 0.0285714286.

Last Split Date	Jul 25, 2016
Split Type	Reverse
Split Ratio	0.0285714286

Scores

FRA:YDO1 has an Altman Z-Score of 6.26 and a Piotroski F-Score of 2.

Altman Z-Score	6.26
Piotroski F-Score	2